Chapter 17: Recombinant DNA Technology & CRISPR

Restriction enzymes function as precise molecular cutting instruments, recognizing and cleaving DNA at specific palindromic sequences to generate either cohesive sticky ends or blunt ends suitable for insertion into vectors. Cloning vectors including plasmids, bacteriophages, bacterial artificial chromosomes, and yeast artificial chromosomes serve as vehicles for replicating foreign DNA within host organisms. The cloning process integrates restriction digestion, vector insertion, and host cell transformation via electroporation or thermal shock methods, with identification of successful recombinants accomplished through selectable antibiotic markers and reporter genes such as the lacZ system. DNA libraries representing complete genomic or complementary DNA collections enable systematic isolation of genes of interest through probe-based library screening. The polymerase chain reaction fundamentally transformed molecular diagnostics and research by enabling exponential amplification of specific DNA sequences in vitro, utilizing thermal cycling, primer annealing, and thermostable polymerases. Derivative PCR approaches including reverse transcription and quantitative real-time variants permit analysis of gene expression and mrna quantification. Molecular characterization relies on gel electrophoresis and blotting methodologies—Southern, Northern, and Western techniques—combined with fluorescence in situ hybridization to visualize and measure nucleic acid and protein distributions. DNA sequencing technologies have advanced from Sanger dideoxynucleotide chain termination through next-generation platforms enabling massively parallel analysis to third-generation long-read technologies providing comprehensive genomic data. Genetic engineering applications encompass knockout and transgenic animal models generated via homologous recombination for functional gene studies and disease modeling, with conditional approaches permitting tissue-specific or inducible gene inactivation. The chapter culminates with CRISPR-Cas9 genome editing, wherein guide RNA-directed endonucleases generate programmable double-strand breaks subsequently repaired through nonhomologous end joining or homology-directed mechanisms, establishing unprecedented precision in genetic modification for research, agriculture, and therapeutic applications while raising significant ethical considerations regarding germline modification.